Evoke Pharma, Inc. (EVOK)

Dec 17, 2025 - EVOK was delisted (reason: acquired by QOL Medical)

11.00

+0.04 (0.36%)

Inactive · Last trade price on Dec 16, 2025

Evoke Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11.58	13.6	4.74	9.84	9.14	8.07
Cash & Short-Term Investments	11.58	13.6	4.74	9.84	9.14	8.07
Cash Growth	2.09%	186.88%	-51.85%	7.64%	13.33%	42.46%
Accounts Receivable	3.19	2.42	0.67	0.62	0.3	0.02
Inventory	0.6	0.45	0.48	0.29	0.19	0.24
Other Current Assets	0.17	0.78	0.93	0.96	0.94	0.95
Total Current Assets	15.54	17.24	6.83	11.72	10.56	9.28
Net Property, Plant & Equipment	0.11	0.15	-	0.13	0.01	0.14
Other Long-Term Assets	0.01	0.13	0.24	-	-	0.01
Total Assets	15.65	17.52	7.07	11.85	10.57	9.43

Liabilities

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Accounts Payable	3.92	2.34	1.71	0.93	0.87	1.27
Accrued Expenses	3.26	2.98	2.94	0.59	0.52	1.02
Short-Term Debt	5	5	5	-	-	0.1
Current Portion of Leases	0.07	0.06	-	0.13	0.01	0.14
Other Current Liabilities	-	-	-	-	-	5
Total Current Liabilities	12.24	10.38	9.65	1.65	1.41	7.54
Long-Term Debt	-	-	-	5	5	5
Long-Term Leases	0.05	0.1	-	-	-	-
Other Long-Term Liabilities	-	-	-	1.11	0.61	0.11
Total Long-Term Liabilities	0.05	0.1	-	6.11	5.61	5.11
Total Liabilities	12.29	10.48	9.65	7.77	7.02	12.65

Shareholders' Equity

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Common Stock	0	0	0	0	0	0
Additional Paid-in Capital	136.19	135.83	120.86	119.73	110.98	95.67
Retained Earnings	-132.82	-128.79	-123.44	-115.65	-107.42	-98.89
Shareholders' Equity	3.36	7.04	-2.58	4.08	3.56	-3.21
Total Liabilities & Equity	15.65	17.52	7.07	11.85	10.57	9.43

Additional Metrics

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Total Debt	5.11	5.16	5	5.13	5.01	5.25
Net Cash (Debt)	6.46	8.44	-0.26	4.71	4.13	2.82
Net Cash Growth	1.97%	-	-	14.09%	46.38%	-48.91%
Net Cash Per Share	2.20	4.43	-0.94	18.00	18.49	15.95
Book Value	3.36	7.04	-2.58	4.08	3.56	-3.21
Book Value Per Share	1.14	3.69	-9.26	15.59	15.91	-18.16
Tangible Book Value	3.36	7.04	-2.58	4.08	3.56	-3.21
Tangible Book Value Per Share	1.14	3.69	-9.26	15.59	15.91	-18.16

SEC Filings: 10-K · 10-Q